User profiles for Philip N Britton

PN Britton

University of Sydney
Verified email at health.nsw.gov.au
Cited by 4317

Vaccines for COVID-19: The current state of play

…, YJ Joo, A Khatami, C Chiu, PN Britton - Paediatric respiratory …, 2020 - Elsevier
There is a strong consensus globally that a COVID-19 vaccine is likely the most effective
approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort …

Off-season RSV epidemics in Australia after easing of COVID-19 restrictions

…, E Cutmore, CC Blyth, PN Britton, N Crawford… - Nature …, 2022 - nature.com
Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection
with the most severe disease in the young and elderly. Non-pharmaceutical interventions …

COVID‐19 in children. II: pathogenesis, disease spectrum and management

…, K Sharma, DK Yeoh, PN Britton - … of paediatrics and …, 2022 - Wiley Online Library
The global disruption of the COVID‐19 pandemic has impacted the life of every child either
directly or indirectly. This review explores the pathophysiology, immune response, clinical …

COVID-19 public health measures and respiratory syncytial virus

PN Britton, N Hu, G Saravanos, J Shrapnel… - The Lancet Child & …, 2020 - thelancet.com
In New South Wales (NSW), Australia, the public health response was highly effective in
controlling the early phase of the COVID-19 pandemic. 1 During this time, clinicians reported …

RSV epidemiology in Australia before and during COVID-19

…, W Rawlinson, A Kesson, R Lingam, PN Britton - …, 2022 - publications.aap.org
… Drs Britton, Lingam, and Homaira conceptualized and designed the study, oversaw data
analysis and interpretation, and reviewed and revised the manuscript; Dr Hu conceptualized …

Vaccines for COVID-19: Where do we stand in 2021?

…, K Nicolopoulos, C Chiu, N Wood, PN Britton - Paediatric respiratory …, 2021 - Elsevier
As of July 2021, over 3 billion doses of a COVID-19 vaccines have been administered
globally, and there are now 19 COVID-19 vaccines approved for use in at least one country. …

Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines

…, PN Britton, JE Clark, CM Cooper, N Curtis… - The Lancet Infectious …, 2016 - thelancet.com
Few studies are available to inform duration of intravenous antibiotics for children and when
it is safe and appropriate to switch to oral antibiotics. We have systematically reviewed …

COVID‐19 in children: I. Epidemiology, prevention and indirect impacts

…, S Tosif, D Wurzel, PN Britton - … of Paediatrics and …, 2022 - Wiley Online Library
Children globally have been profoundly impacted by the coronavirus disease 2019 (COVID‐19)
pandemic. This review explores the direct and indirect public health impacts of COVID‐…

SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings

…, P Palasanthiran, PE Gray, BJ McMullan, PN Britton… - Pathology, 2020 - Elsevier
As the SARS-CoV-2 pandemic unfolds across the globe, consistent themes are emerging with
regard to aspects of SARS-CoV-2 infection and its associated disease entities in children. …

Parechovirus encephalitis and neurodevelopmental outcomes

PN Britton, RC Dale, MD Nissen, N Crawford… - …, 2016 - publications.aap.org
OBJECTIVE: We aimed to describe the clinical features and outcome of human parechovirus
(HPeV) encephalitis cases identified by the Australian Childhood Encephalitis (ACE) study. …